Dr. Elizabeth J. Davis
Claim this profileVanderbilt University/Ingram Cancer Center
Studies Sarcoma
Studies Tumors
16 reported clinical trials
21 drugs studied
About Elizabeth J. Davis
Education:
- Obtained MD from Vanderbilt University School of Medicine in 2009.
- Completed Residency in Internal Medicine at Vanderbilt University Medical Center in 2012.
- Finished Fellowship in Hematology/Oncology at Vanderbilt University Medical Center in 2015.
Experience:
- Specializes in hematology and oncology at Ingram Cancer Center, Vanderbilt University Medical Center.
- Serves as Assistant Professor of Medicine at Vanderbilt University Medical Center.
Area of expertise
1Sarcoma
Stage IV
EWSR1/ATF1 positive
EWSR1/CREB1 positive
2Tumors
Stage IV
Stage III
IDH positive
Affiliated Hospitals
Clinical Trials Elizabeth J. Davis is currently running
INBRX-109
for Chondrosarcoma
This trial tests INBRX-109, a specially designed protein, in patients with a hard-to-treat type of bone cancer. The treatment helps the immune system target and kill cancer cells by attaching to a specific marker on these cells.
Recruiting0 awards Phase 26 criteria
CAB-AXL-ADC + PD-1 Inhibitor
for Sarcoma
This trial is testing mecbotamab vedotin, a medicine that targets and kills cancer cells, in patients with advanced solid tumors, including specific types of sarcomas. It works by using an antibody to find the cancer cells and a drug to destroy them.
Recruiting1 award Phase 1 & 2
More about Elizabeth J. Davis
Clinical Trial Related4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Elizabeth J. Davis has experience with
- Atezolizumab
- Olaparib
- Pembrolizumab
- INBRX-109
- Bevacizumab
- Nivolumab
Breakdown of trials Elizabeth J. Davis has run
Sarcoma
Tumors
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elizabeth J. Davis specialize in?
Elizabeth J. Davis focuses on Sarcoma and Tumors. In particular, much of their work with Sarcoma has involved Stage IV patients, or patients who are EWSR1/ATF1 positive.
Is Elizabeth J. Davis currently recruiting for clinical trials?
Yes, Elizabeth J. Davis is currently recruiting for 4 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Elizabeth J. Davis has studied deeply?
Yes, Elizabeth J. Davis has studied treatments such as Atezolizumab, Olaparib, Pembrolizumab.
What is the best way to schedule an appointment with Elizabeth J. Davis?
Apply for one of the trials that Elizabeth J. Davis is conducting.
What is the office address of Elizabeth J. Davis?
The office of Elizabeth J. Davis is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.